Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations and Comprehensive Loss (Unaudited)

v3.20.2
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating expenses:        
Research and development $ 5,650 $ 3,220 $ 15,601 $ 8,645
General and administrative 2,766 1,811 8,902 4,178
Total operating expenses 8,416 5,031 24,503 12,823
Loss from operations (8,416) (5,031) (24,503) (12,823)
Other income:        
Interest income 23 381 473 1,283
Net loss (8,393) (4,650) (24,030) (11,540)
Deemed dividend       (5,326)
Net loss attributable to common stockholders (8,393) (4,650) (24,030) (16,866)
Other comprehensive income:        
Net unrealized gain on available-for-sale investments, net of tax 1   12  
Net comprehensive loss $ (8,392) $ (4,650) $ (24,018) $ (16,866)
Net loss per share of voting and non-voting common stock, basic and diluted $ (0.36) $ (2.17) $ (1.09) $ (9.34)